Developer docs
API playgroundTry for free, no card

Search company profiles

IlluminOss Medical

Full company profile

uuid0004315

Namestring
IlluminOss Medical
Legal namestring
IlluminOss Medical, Inc.
Websiteurl
illuminoss.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

IlluminOss Medical is a privately held commercial-stage medical device company founded in 2007 and headquartered in East Providence, Rhode Island. The company develops and markets the Photodynamic Bone Stabilization System, a minimally invasive intramedullary implant for the treatment of bone fractures in compromised bone. The system delivers a biocompatible light-curable liquid monomer through a flexible balloon catheter into the intramedullary canal, where it is hardened in situ by visible blue light from a proprietary LED console to form a patient-conforming implant that conforms exactly to the patient's anatomy and provides longitudinal and rotational stability.

The company holds FDA 510(k) clearances across multiple anatomical indications including humerus, pelvis, femur, tibia, radius/ulna, fibula, and clavicle, and is CE Marked for sale in the European Union. Its primary clinical positioning targets fragility fractures in osteoporotic geriatric patients and pathologic fractures in oncology patients (e.g., multiple myeloma), where traditional metal hardware has high failure rates due to poor bone quality. A portfolio of 27+ granted US patents protects the underlying photodynamic method and device architecture. The company operates a wholly-owned subsidiary, ABL Medical, established in February 2024 to develop anti-microbial blue light fiber technology.

IlluminOss generates revenue through sale of procedure packs (implant balloon catheters in various sizes) and LED light consoles to hospitals and orthopedic surgeons, using a hybrid direct field sales force and distributor network covering the US and EU. It markets to orthopedic surgeons, trauma specialists, and hospitals performing fracture repair procedures, with two primary patient segments: geriatric/osteoporotic patients and oncology/bone cancer patients. In May 2020, HealthpointCapital acquired a majority stake to support commercial expansion. The company is majority owned by HealthpointCapital and operates with 11–50 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEast Providence, United States
HQ citystring
East Providence
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic medical devices, fracture repair systems, intramedullary implants, photodynamic bone stabilization, minimally invasive orthopedics
Industry2 codes
PRIMARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

IlluminOss generates revenue through the sale of their Photodynamic Bone Stabilization System implants and associated instruments/procedure packs to hospitals and orthopedic surgeons. The system involves one-time procedural revenue from implant sales for fracture repair surgeries.

illuminoss.com
2Procedure Packs and Consumables
TypeHardware Sales
Description

Sale of procedure packs (Photodynamic Bone Stabilization Procedure Packs) in various sizes specifications and light console systems as consumables for ongoing surgical procedures.

illuminoss.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Procedure Packs - Multiple size configurations
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Various procedure pack sizes available including 4x30mm through 8x70mm (MS series) and longer lengths (SL and ML series) ranging from 7mm to 22mm diameter with varying lengths. US and international versions available.

illuminoss.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

IlluminOss Medical develops and commercializes the Photodynamic Bone Stabilization System, a minimally invasive orthopedic implant system that uses a light-curable polymer contained within an expandable balloon catheter to create a patient-conforming intramedullary implant for fracture repair. The system includes the LED light curing console and various procedure pack size configurations for treating traumatic, fragility, and pathologic fractures in compromised bone.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Patients typically return to daily activities within days of procedure
+2 more records
Product overview1 text field

IlluminOss Medical offers a single unified product system — the IlluminOss Photodynamic Bone Stabilization System — consisting of proprietary balloon catheter implants that deliver a light-curable polymer into the intramedullary canal, and the accompanying LED Light Curing System console used to activate and harden the implant. The system is designed for minimally invasive fracture repair in compromised bone (osteoporotic and pathologic fractures). The portfolio includes various implant size configurations (MS-, SL-, and ML-series procedure packs) and compatible instruments for different anatomical applications (humerus, pelvis, femur, radius/ulna, fibula, tibia). The company operates as a commercial-stage medical device firm with FDA clearance in the US and CE marking in the EU.

Product and service1 record
1IlluminOss Photodynamic Bone Stabilization System
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the world's largest orthopedic medical device companies with a broad trauma and extremities portfolio including intramedullary nails and fracture fixation systems. Competes with IlluminOss across the fracture repair market but at vastly greater scale and with metal hardware rather than light-cured polymers.

TypeBroad incumbent
Description

Global orthopedic device manufacturer with a comprehensive trauma and extremities product line. Competes with IlluminOss in fracture fixation across both US and EU markets with significantly greater sales and R&D resources.

TypeBroad incumbent
Description

Diversified medical device company with a strong orthopedic trauma and extremities franchise including intramedullary nails and plating systems. Direct competitor in fracture repair and minimally invasive orthopedic surgery.

TypeBroad incumbent
Description

Specialty orthopedic company historically focused on extremities and biologics, now part of Stryker's trauma and extremities business. Comparable extremities trauma focus overlapping with IlluminOss's fragility fracture positioning.

TypeDirect peer
Description

Specialty orthopedic company focused on fracture repair, spine, and orthopedic再生 products with a similar size and growth-stage profile to IlluminOss. Targets many of the same orthopedic surgeons and trauma indications, including extremity and fragility fracture applications.

TypeDirect peer
Description

Specialty orthopedic trauma and extremities company focused on upper and lower extremity fracture repair. Similar niche orthopedic trauma positioning to IlluminOss with comparable customer base of trauma surgeons.

TypeBroad incumbent
Description

Orthopedic and neurosurgical device company with extremities and trauma fixation products serving similar orthopedic surgeon customers. Overlaps with IlluminOss in orthopedic trauma, though its portfolio is broader and metal-hardware based.

TypeBroad incumbent
Description

Market-leading orthopedic trauma franchise offering plates, screws, nails, and external fixation for fracture repair. Direct competitor to IlluminOss in the trauma surgery market, with established surgeon relationships and broad hospital contracts.

TypeEmerging player
Description

Emerging orthopedic device company developing minimally invasive fracture fixation technologies for periarticular and extremity fractures. Closely comparable to IlluminOss in both size and focus on novel minimally invasive fracture repair approaches.

TypeEmerging player
Description

Smaller specialty orthopedic company developing plates, screws, and fixation systems for extremity trauma. Comparable scale and trauma-focused positioning, selling to many of the same orthopedic surgeon customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IlluminOss Medical

Orthopedic Medical Devicesilluminoss.com

What IlluminOss Medical does

IlluminOss Medical is a privately held commercial-stage medical device company founded in 2007 and headquartered in East Providence, Rhode Island. The company develops and markets the Photodynamic Bone Stabilization System, a minimally invasive intramedullary implant for the treatment of bone fractures in compromised bone. The system delivers a biocompatible light-curable liquid monomer through a flexible balloon catheter into the intramedullary canal, where it is hardened in situ by visible blue light from a proprietary LED console to form a patient-conforming implant that conforms exactly to the patient's anatomy and provides longitudinal and rotational stability.

The company holds FDA 510(k) clearances across multiple anatomical indications including humerus, pelvis, femur, tibia, radius/ulna, fibula, and clavicle, and is CE Marked for sale in the European Union. Its primary clinical positioning targets fragility fractures in osteoporotic geriatric patients and pathologic fractures in oncology patients (e.g., multiple myeloma), where traditional metal hardware has high failure rates due to poor bone quality. A portfolio of 27+ granted US patents protects the underlying photodynamic method and device architecture. The company operates a wholly-owned subsidiary, ABL Medical, established in February 2024 to develop anti-microbial blue light fiber technology.

IlluminOss generates revenue through sale of procedure packs (implant balloon catheters in various sizes) and LED light consoles to hospitals and orthopedic surgeons, using a hybrid direct field sales force and distributor network covering the US and EU. It markets to orthopedic surgeons, trauma specialists, and hospitals performing fracture repair procedures, with two primary patient segments: geriatric/osteoporotic patients and oncology/bone cancer patients. In May 2020, HealthpointCapital acquired a majority stake to support commercial expansion. The company is majority owned by HealthpointCapital and operates with 11–50 employees.

IlluminOss Medical firmographics

Firmographics
Name
IlluminOss Medical
Legal name
IlluminOss Medical, Inc.
Website
https://illuminoss.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

IlluminOss Medical industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Orthopedic medical devices
  • Fracture repair systems
  • Intramedullary implants
  • Photodynamic bone stabilization
  • Minimally invasive orthopedics

Where IlluminOss Medical is headquartered

Location

Headquarters

HQ city
East Providence
HQ country
United States
HQ region
North America

Offices1 record

Markets served

IlluminOss Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Device Sales: IlluminOss generates revenue through the sale of their Photodynamic Bone Stabilization System implants and associated instruments/procedure packs to hospitals and orthopedic surgeons. The system involves one-time procedural revenue from implant sales for fracture repair surgeries.
  2. Procedure Packs and Consumables: Sale of procedure packs (Photodynamic Bone Stabilization Procedure Packs) in various sizes specifications and light console systems as consumables for ongoing surgical procedures.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goProcedure Packs - Multiple size configurations

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

IlluminOss Medical product offering

Product offering

Core offering

IlluminOss Medical develops and commercializes the Photodynamic Bone Stabilization System, a minimally invasive orthopedic implant system that uses a light-curable polymer contained within an expandable balloon catheter to create a patient-conforming intramedullary implant for fracture repair. The system includes the LED light curing console and various procedure pack size configurations for treating traumatic, fragility, and pathologic fractures in compromised bone.

Product overview

IlluminOss Medical offers a single unified product system — the IlluminOss Photodynamic Bone Stabilization System — consisting of proprietary balloon catheter implants that deliver a light-curable polymer into the intramedullary canal, and the accompanying LED Light Curing System console used to activate and harden the implant. The system is designed for minimally invasive fracture repair in compromised bone (osteoporotic and pathologic fractures). The portfolio includes various implant size configurations (MS-, SL-, and ML-series procedure packs) and compatible instruments for different anatomical applications (humerus, pelvis, femur, radius/ulna, fibula, tibia). The company operates as a commercial-stage medical device firm with FDA clearance in the US and CE marking in the EU.

Differentiator

Problem solved

Functional benefit

Products and services

  • IlluminOss Photodynamic Bone Stabilization System

Quantifiable outcome

  • Patients typically return to daily activities within days of procedure
  • +2 more outcomes

Companies that use IlluminOss Medical

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles1 record

IlluminOss Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

IlluminOss Medical partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

IlluminOss Medical competitors and assessment

Company assessment

Broad incumbents

  • Stryker: One of the world's largest orthopedic medical device companies with a broad trauma and extremities portfolio including intramedullary nails and fracture fixation systems. Competes with IlluminOss across the fracture repair market but at vastly greater scale and with metal hardware rather than light-cured polymers.
  • Zimmer Biomet: Global orthopedic device manufacturer with a comprehensive trauma and extremities product line. Competes with IlluminOss in fracture fixation across both US and EU markets with significantly greater sales and R&D resources.
  • Smith+Nephew: Diversified medical device company with a strong orthopedic trauma and extremities franchise including intramedullary nails and plating systems. Direct competitor in fracture repair and minimally invasive orthopedic surgery.
  • Wright Medical Group (now part of Stryker): Specialty orthopedic company historically focused on extremities and biologics, now part of Stryker's trauma and extremities business. Comparable extremities trauma focus overlapping with IlluminOss's fragility fracture positioning.
  • Integra LifeSciences: Orthopedic and neurosurgical device company with extremities and trauma fixation products serving similar orthopedic surgeon customers. Overlaps with IlluminOss in orthopedic trauma, though its portfolio is broader and metal-hardware based.
  • Johnson & Johnson (DePuy Synthes): Market-leading orthopedic trauma franchise offering plates, screws, nails, and external fixation for fracture repair. Direct competitor to IlluminOss in the trauma surgery market, with established surgeon relationships and broad hospital contracts.

Direct peers

  • Orthofix Medical: Specialty orthopedic company focused on fracture repair, spine, and orthopedic再生 products with a similar size and growth-stage profile to IlluminOss. Targets many of the same orthopedic surgeons and trauma indications, including extremity and fragility fracture applications.
  • Acumed: Specialty orthopedic trauma and extremities company focused on upper and lower extremity fracture repair. Similar niche orthopedic trauma positioning to IlluminOss with comparable customer base of trauma surgeons.

Emerging players

  • Conventus Orthopaedics: Emerging orthopedic device company developing minimally invasive fracture fixation technologies for periarticular and extremity fractures. Closely comparable to IlluminOss in both size and focus on novel minimally invasive fracture repair approaches.
  • Tyber Medical: Smaller specialty orthopedic company developing plates, screws, and fixation systems for extremity trauma. Comparable scale and trauma-focused positioning, selling to many of the same orthopedic surgeon customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

IlluminOss Medical social profiles

Digital presence

IlluminOss Medical compliance and trust

Trust signal

Compliance2 records

IlluminOss Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IlluminOss Medical leadership team

Management profile

Number of profiles

Profiles2 records

IlluminOss Medical subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

IlluminOss Medical funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IlluminOss Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IlluminOss Medical

What does IlluminOss Medical do?

IlluminOss Medical develops and commercializes the Photodynamic Bone Stabilization System, a minimally invasive orthopedic implant system that uses a light-curable polymer contained within an expandable balloon catheter to create a patient-conforming intramedullary implant for fracture repair. The system includes the LED light curing console and various procedure pack size configurations for treating traumatic, fragility, and pathologic fractures in compromised bone.

Is IlluminOss Medical a public or private company?

IlluminOss Medical is a private company. It is classified as private equity controlled and is currently operating.

When was IlluminOss Medical founded?

IlluminOss Medical was founded in 2007. It employs 11 to 50 people.

Where is IlluminOss Medical based?

IlluminOss Medical is headquartered in East Providence, United States, in the North America region.

How does IlluminOss Medical make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are procedure Packs and Consumables.

Who are IlluminOss Medical's main competitors?

Broad incumbents on record are Stryker, Zimmer Biomet, Smith+Nephew, Wright Medical Group (now part of Stryker), Integra LifeSciences and Johnson & Johnson (DePuy Synthes). Direct peers are Orthofix Medical and Acumed. Emerging players are Conventus Orthopaedics and Tyber Medical.

Does IlluminOss Medical have an API?

No public API is recorded for IlluminOss Medical.

What industry is IlluminOss Medical in?

IlluminOss Medical's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFall today, move tomorrow! Local news story highlights using IlluminOss to fix an older patient's fracture to deliver fast rehabilitation instead of immobilizationIlluminOss Medical announced that its minimally-invasive bone fracture repair technology was featured on Rhode Island Channel 10 News, showcasing a case in which an elderly patient with a two-part upper arm fracture was treated by Dr. Anthony Deluise from Ortho Rhode Island using the IlluminOss Photodynamic Bone Stabilization System. The patient, Deborah, was able to begin physical therapy within two weeks and regained full range of motion, compared to the typical two-to-three month immobilization period for such fractures. Dr. Deluise described the IlluminOss system as a 'game changer' that results in minimal post-surgical pain and rapid readiness for rehabilitation.PR NewswireIlluminOss Subsidiary ABL Medical Developing Anti-Microbial Blue Light Fiber Technology!ABL Medical Inc., a subsidiary of IlluminOss Medical, has developed antimicrobial blue light fiber technology for use in medical devices such as catheters and endotracheal tubes. The technology delivers specific frequencies of blue light via fiber-optic catheters to inactivate pathogens by causing overproduction of reactive oxygen species that damage microbial cell structures. The company has presented laboratory data at major 2023 medical conferences and is now pursuing regulatory review processes to investigate clinical safety and effectiveness.PR NewswireIlluminOss announces their 200th patient in their global device registry, studying the effectiveness and patient outcomes of their revolutionary device for addressing bone fracturesIlluminOss Medical announced it has enrolled over 200 patients in its global device registry across 16 sites, studying the safety and performance of its Photodynamic Bone Stabilization System for treating fractures in compromised bone. The registry collects follow-up data at 75 days, 6 months, and 1 year, with over half of enrolled patients already reaching their first follow-up visit. The company plans to present the registry results at the upcoming American Academy of Orthopedic Surgeons meeting.PR NewswireIlluminOss Medical Receives FDA Clearance for Use in Femur and Tibia Fractures as a Supplement to Approved HardwareIlluminOss Medical received expanded FDA 510(k) clearance for its Photodynamic Bone Stabilization System to treat femur and tibia fractures. This approval allows the device to be used as supplemental fixation to traditional hardware, addressing challenges with osteoporotic bone in elderly patients. The technology has been in clinical use in the US since 2018 with over 4,000 procedures performed.PR NewswireIlluminOss Medical Receives FDA Clearance for Use in Fibula FracturesIlluminOss Medical received expanded FDA 510(k) clearance for its Photodynamic Bone Stabilization System to treat fibula fractures. This regulatory approval adds the fibula to the system's previously cleared indications, which include other bones such as the humerus and pelvis. The expansion supports the company's strategy of providing minimally invasive fracture repair options for elderly patients.PR NewswireIlluminOss Medical Receives FDA Clearance for Expanded Clinical Use for Pelvic, Clavicle and Small-Bone FracturesIlluminOss Medical received expanded FDA 510(k) clearance for its Photodynamic Bone Stabilization System to treat fractures of the pelvis, clavicle, and small bones of the hands and feet (metacarpals, metatarsals, and phalanges). The system uses a light-curable liquid polymer contained within an expandable balloon to create a patient-conforming intramedullary implant. The technology has been in clinical use in Europe since 2010 with over 4,000 procedures, and was previously cleared in the US for humerus, radius, and ulna fractures.PR NewswireHealthpointCapital Acquires Majority Stake in IlluminOss Medical, Inc.HealthpointCapital acquired a majority stake in IlluminOss Medical, Inc., a medical device company specializing in minimally invasive fracture repair technology. The investment aims to accelerate regulatory approvals for additional anatomical indications and expand the commercialization of its Photodynamic Bone Stabilization System. Transaction financial details were not disclosed.FierceBiotechIlluminOss launches patient-specific light-activated bone bonder for fragile broken armsIlluminOss Medical launched a photodynamic bone fixative for arm fractures in the U.S. market. The system uses an expandable balloon implant cured with blue light, and the FDA cleared it in August 2018 for humerus, radius, and ulna fractures. The company reports reduced hospital stays and shorter procedures.FierceBiotechSarepta Therapeutics Announces Corporate Update and Report on Recent Data from Phase IIb Study of Eteplirsen for Duchenne Muscular DystrophySarepta Therapeutics will host a live webcast and conference call on October 1, 2015, for interim CEO Edward Kaye to present a corporate update and recent data from the Phase IIb study of eteplirsen for Duchenne muscular dystrophy. The call will include a panel discussion with experts, and the webcast will be archived for 90 days.GlobeNewswireIlluminOss Medical Receives Clearance to Expand ClinicalIlluminOss Medical announced FDA clearance for its Photodynamic Bone Stabilization System in skeletally mature patients for traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, and ulna. The system, initially cleared in January 2018 for metastatic bone disease, is now commercially available in the U.S. and has been in clinical use since 2010.